Orange Book product · Brand (NDA)
PHENYLEPHRINE HYDROCHLORIDE
PHENYLEPHRINE HYDROCHLORIDE
At a glance
Mar 21, 2013
Approved
Brand (NDA)
Application
AT
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 21, 2013
13 yr 5 mo ago
Today
Patent 8859623 expires
Listed method-of-use patent (U-1594) expiration.
Nov 14, 2033
in 7 yr 6 mo
Pharmaceutical detail
Active ingredient
PHENYLEPHRINE HYDROCHLORIDE
Strength
2.5%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AT
Application
NDA 203510
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDEBrand (NDA)
NDA 216830 · DR REDDYS LABS SA
- 2023IMMPHENTIVBrand (NDA)
NDA 203826 · HIKMA
- 2019BIORPHENBrand (NDA)
NDA 212909 · DR REDDYS LABS SA
- 2015PHENYLEPHRINE HYDROCHLORIDEBrand (NDA)
NDA 207926 · ALCON
- 2014VAZCULEPBrand (NDA)
NDA 204300 · EXELA PHARMA
- 2026PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217032 · BAXTER HLTHCARE CORP
- 2025PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215617 · SOMERSET THERAPS LLC
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218129 · GLAND
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215183 · CAPLIN
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218110 · ASPIRO
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218412 · HAINAN POLY
- 2023PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217521 · BE PHARMS
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8859623 | Nov 14, 2033 | in 7 yr 6 mo | U-1594 |

